These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 10193519)
1. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype. De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519 [TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899 [TBL] [Abstract][Full Text] [Related]
4. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Ravi R; Bedi A Cancer Res; 2002 Mar; 62(6):1583-7. PubMed ID: 11912124 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. Sturm I; Köhne CH; Wolff G; Petrowsky H; Hillebrand T; Hauptmann S; Lorenz M; Dörken B; Daniel PT J Clin Oncol; 1999 May; 17(5):1364-74. PubMed ID: 10334520 [TBL] [Abstract][Full Text] [Related]
6. Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer. Paradiso A; Simone G; Lena MD; Leone B; Vallejo C; Lacava J; Dellapasqua S; Daidone MG; Costa A Br J Cancer; 2001 Mar; 84(5):651-8. PubMed ID: 11237386 [TBL] [Abstract][Full Text] [Related]
7. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia. Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR J Cancer Res Clin Oncol; 2000 Jan; 126(1):62-7. PubMed ID: 10641752 [TBL] [Abstract][Full Text] [Related]
8. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia. Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Jiang M; Milner J Genes Dev; 2003 Apr; 17(7):832-7. PubMed ID: 12670866 [TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by p53, bax, bcl-2, and p21 expressed in colorectal cancer. Katsumata K; Sumi T; Tomioka H; Aoki T; Koyanagi Y Int J Clin Oncol; 2003 Dec; 8(6):352-6. PubMed ID: 14663636 [TBL] [Abstract][Full Text] [Related]
11. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas. Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939 [TBL] [Abstract][Full Text] [Related]
12. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
13. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis. Nomura M; Watari J; Yokota K; Saitoh Y; Obara T; Kohgo Y Virchows Arch; 2000 Jul; 437(1):17-24. PubMed ID: 10963375 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Xie X; Clausen OP; De Angelis P; Boysen M Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515 [TBL] [Abstract][Full Text] [Related]
15. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2 and Bax in oligodendrogliomas and their relationship to apoptosis. Delgado MB; Anderson JR; Whittle IR; Wharton SB Neuropathol Appl Neurobiol; 1999 Oct; 25(5):400-7. PubMed ID: 10564530 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases. Backus HH; Van Groeningen CJ; Vos W; Dukers DF; Bloemena E; Wouters D; Pinedo HM; Peters GJ J Clin Pathol; 2002 Mar; 55(3):206-11. PubMed ID: 11896073 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Jordan RC; Catzavelos GC; Barrett AW; Speight PM Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):394-400. PubMed ID: 9039223 [TBL] [Abstract][Full Text] [Related]
19. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Violette S; Poulain L; Dussaulx E; Pepin D; Faussat AM; Chambaz J; Lacorte JM; Staedel C; Lesuffleur T Int J Cancer; 2002 Apr; 98(4):498-504. PubMed ID: 11920608 [TBL] [Abstract][Full Text] [Related]
20. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]